AVIR Earnings

Quarterly EPS
$-0.37
Q3 2024
$-0.40
Q4 2024
$-0.40
Q1 2025
$-0.44
Q2 2025
$-0.53
Q3 2025
$-0.58
Q4 2025
$-0.57
Q1 2026
$-0.41
Q2 2026
Latest RevenueN/A
Latest Net Income-32933000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.410-32933000+6.8%
Q1 2026-$0.570-45440000-42.5%
Q4 2025-$0.580-44867000-45.0%
Q3 2025-$0.530-42049000-43.2%
Q2 2025-$0.440-37161000+8.3%
Q1 2025-$0.400-34272000+46.7%
Q4 2024-$0.400-33543000+14.9%
Q3 2024-$0.370-31151000+7.5%
Q2 2024-$0.480-40522000
Q1 2024-$0.750-63169000
Q4 2023-$0.470-39164000
Q3 2023-$0.400-33142000
Atea Pharmaceuticals (AVIR) — Earnings